type 1 diabetes Archives -

Sanofi builds case for Toujeo in younger type 1 diabetics

https://pharmaphorum.com/news/sanofi-builds-case-for-toujeo-in-younger-type-1-diabetics/

Astellas cuts $795m deal with Pandion for type 1 diabetes drugs

https://pharmaphorum.com/news/astellas-biotech-deal-pandion-diabetes/

Giving patients a sense of belonging

https://pharmaphorum.com/views-analysis-patients/giving-patients-a-sense-of-belonging/

Vertex looks beyond cystic fibrosis with $950m Semma buy

https://pharmaphorum.com/news/vertex-looks-beyond-cystic-fibrosis-with-950m-semma-buy/

Relief for GSK as Tesaro’s Zejula hits the mark in ovarian cancer

https://pharmaphorum.com/news/relief-for-gsk-as-tesaros-zejula-hits-the-mark-in-ovarian-cancer/

FDA unconvinced by Sanofi’s Zynquista in type 1 diabetes

https://pharmaphorum.com/news/fda-unconvinced-by-sanofis-zynquista-in-type-1-diabetes/

FDA advisers divided on Sanofi’s oral type 1 diabetes drug

https://pharmaphorum.com/news/fda-divided-on-sanofis-oral-type-1-diabetes-drug/

Novo to create California stem cell therapy manufacturing site

https://pharmaphorum.com/news/novo-to-create-california-stem-cell-therapy-manufacturing-site/

Novo expands type 1 diabetes R&D

https://pharmaphorum.com/news/novo-expands-type-1-diabetes-rd/

Search